[Retracted] Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma

<div>A hybrid nomogram. The hybrid nomogram was accurate, which demonstrated great potential in the therapy of LUSC patients.</div>

Disease Markers

fig6

Figure 6

Figure 6: [Retracted] Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma 

Figure 6 | [Retracted] Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma 